Dare Bioscience Inc 2020 Corporate Update - Call Transcript
Welcome to the conference call hosted by Daré Bioscience to review the company's recent announcement regarding its license agreement with Bayer and to provide general business update. This call is being recorded. My name is Jonathan, and I will be your operator today. With us today are Sabrina Martucci Johnson, Daré's President and Chief Executive Officer; John Fair, Chief Business Officer; and Lisa Walters-Hoffert, Chief Financial Officer. Ms. Johnson, please proceed.
© -
Thank you. Welcome to the business update call for Daré Bioscience. It is an absolute pleasure to have the opportunity to discuss our recent announcement and highlight some of the other milestones we expect for our later-stage assets in 2020.
Before I begin, I'd like to remind you that today's discussion will include forward-looking statements within the meaning of federal securities laws which are made pursuant to the safe harbor provisions of the Private Securities
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
